Polypeptide exhibiting affinity to antibodies forming non-native three-dimensional structure

Inhibitory antibodies against MMP-14

Anti-plasma kallikrein antibodies

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

Antibodies that recognize red blood cell antigens

Antibody directed against the endothelin receptor beta sub-type

AGENTS THAT NEUTRALIZE IL-3 SIGNALLING AND USES THEREOF

Anti-CTLA4 and anti-PD-1 bifunctional antibody, pharmaceutical composition thereof and use thereof

Antigen Binding Molecules comprising a TNF family ligand trimer and PD1 binding moiety

Anti-TIM-3 antibodies

Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof

CD47 antibodies and uses thereof for treating cancer

Site directed mutagenesis of TREM-1 antibodies for decreasing viscosity

Methods for producing antibodies promoting disappearance of antigens having plurality of biological activities

Targeting CLPTM1L for treatment and prevention of cancer

Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS

Human antibody against ED-B domain of fibronectin and uses thereof

Anti-HSV synergistic activity of antibodies and antiviral agents

HIGH-THROUGHPUT SCREENING ASSAY

Single domain antibodies directed against intracellular antigens

SINGLE-DOMAIN ANTIGEN-BINDING PROTEINS THAT BIND MAMMALIAN IGG

Host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1 and antibody production

Antibody targeted to tissue factor, preparation method therefor, and use thereof

Anti-HER2 antibodies and immunoconjugates

Anti-fibulin-3 antibodies and uses thereof

Anti-OX40 binding proteins

Anti-Axl antagonistic antibodies

Anti-Axl antibodies, antibody fragments and their immunoconjugates and uses thereof

Anti-C10ORF54 antibodies and uses thereof

Anti-CTLA4 antibodies

Fusion protein comprising apelin and an anti-APLNR antibody

Antibodies to TGF-β

Antibodies specific for hyperphosphorylated tau and methods of use thereof

Afucosylated anti-FGFR2IIIB antibodies

Anti-ICOS agonist antibodies and uses thereof

Animal models and therapeutic molecules

Humanised anti kallikrein-2 antibody

NOVEL BISPECIFIC POLYPEPTIDES AGAINST CD137

GLYCOPROTEIN V INHIBITORS FOR USE AS COAGULANTS

Recombinant obligate anaerobic Gram-positive bacteria

Variant antibodies that bind OX40

Anti-CD40 antibodies

Combination of glucagon receptor antagonists and PI3K pathway inhibitors for the treatment of cancer

LONG LIFE POLYPEPTIDE BINDING MOLECULES

Antibodies to MAdCAM

Optimized PNE-based chimeric receptor T cell switches and uses thereof

Antagonists of IL-6 to prevent or treat thrombosis

Method for treating IL-8-related diseases

Anti-IL31 Antibodies for Veterinary Use

Anti-CXCR5 antibodies and compositions and uses thereof

Methods for blocking an interaction between notch-1 and delta-like 4 (DLL-4) by administering a DDL-4 antibody

ANGPTL8-binding agents and methods of use thereof

Modified anti-tenascin antibodies and methods of use

Humanized tau antibodies in alzheimer's disease

HUMAN ANTI-TAU ANTIBODIES

Constructs having a SIRP-alpha domain or variant thereof

ANTI-T. CRUZI ANTIBODIES AND METHODS OF USE

Fusion protein construct

Antibody therapeutics that bind CD137

Anti-TrkB monoclonal antibodies and methods of use

Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof

SP35 Antibodies And Uses Thereof

Combination therapy

Antibodies specific to Sonic Hedgehog and method of use thereof

Synthetic antibodies to BAX and uses thereof

Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders

COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

HCMV entry inhibitors

Antibodies binding AXL

MRNA display antibody library and methods

Multi-specific monoclonal antibodies

Chimeric polypeptide assembly and methods of making and using the same

Compositions and methods for the depletion of CD117+ cells

CD39 VASCULAR ISOFORM TARGETING AGENTS

Anti-LAG-3 antibodies

Anti-CD40 antibodies for use in treatment of Sjögren's syndrome

Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke

Monoclonal antibodies to fibroblast growth factor receptor 2

Anti-BMPR1B antibodies and methods of use

Anti-CTLA-4 antibodies

CD3/CD33 BISPECIFIC BINDING MOLECULES

Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof

Anti-ROR1 antibodies

Humanized anti-BAG3 antibodies

Anti-TNFα-antibodies and functional fragments thereof

Anti eotaxin-2 antibodies that recognize additional CCR3-binding chemokines

Heterodimeric immunoglobulins

ANTIBODIES TARGETING BONE MORPHOGENETIC PROTEIN 9 (BMP9) AND METHODS THEREFOR

Humanized antibodies that recognize alpha-synuclein

Anti-complement factor BB antibodies and uses thereof

Antibodies against toxins and methods of using the same

O3 specific antibodies

Antibody molecules to dengue virus and uses thereof

ANTIBODIES THAT NEUTRALIZE RSV, MPV AND PVM AND USES THEREOF

Bispecific EGFR/IGFIR binding molecules

Anti-BCMA chimeric antigen receptor

Compositions for inhibiting fibrin-VLDL receptor-dependent inflammation and methods of treatment

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

Nucleic acids encoding antibodies with high affinity for Alpha-Klotho

Anti-IgE antibodies

Anti-TROP2 antibody-drug conjugate

Compositions and methods for the depletion of CD117+ cells

Antagonistic anti-tumor necrosis factor receptor 2 antibodies

Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof

Nucleic acid molecules encoding antibodies to the human glucagon receptor

Chimeric antigen receptors targeting epidermal growth factor receptor variant III

Anti-PD-1 antibodies and uses thereof

Anti-PD-1 antibodies and compositions

Anti-PD-1 monoclonal antibody and obtaining method therefor

Anti-Notch3 antibody

Method of reducing tumor growth with IL-1beta neutralizing human monoclonal antibodies

ANTI-IL-23 ANTIBODIES

Nucleic acids encoding binding members to TNF alpha

Binding domain or antibody specific to a human serum albumin (HSA)

Anti-PCSK9 antibodies

Anti-jagged antibodies and methods of use

COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES

B cell maturation antigen binding proteins

AGONISTIC ANTI-TUMOR NECROSIS FACTOR RECEPTOR 2 ANTIBODIES

ANTI CD25 FC GAMMA RECEPTOR BISPECIFIC ANTIBODIES FOR TUMOR SPECIFIC CELL DEPLETION

Anti-CTLA-4 antibodies and methods of use thereof

ANTIBODY BINDING TO FCRN FOR TREATING AUTOIMMUNE DISEASES

Humanized affinity matured anti-FcRn antibodies

Engineered T cell receptors and immune therapy using the same

Compositions and methods for antibodies targeting EPO

Interferon Alpha and Omega Antibody Antagonists

Antibodies against growth differentiation factor 15 and uses thereof

ANG2-BINDING MOLECULES

Anti-APOC3 antibodies and compositions thereof

Method of producing antibody fragment

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD117+ CELLS

Humanized universal light chain mice

Dual specificity antibody fusions

Antibodies to matrix metalloproteinase 9

Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof

Anti-PD-1 antibodies, method for producing same and method for using same

Anti-SIRPa antibodies and their therapeutic applications

Anti-sortilin antibodies and methods of use thereof

Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1

High affinity B7-H6 antibodies and antibody fragments

Antibody therapeutics that bind CTLA4

Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof

PD-1-binding molecules and methods of use thereof

Method of eliminating hematopoietic stem cells/hematopoietic progenitors (HSC/HP) in a patient using bi-specific antibodies

Anti-IL-22R antibodies

Anti-IL8 antibodies

Fc-region variants with improved protein A-binding

Non-glycosylated anti-tenascin antibody

Therapy of multiple organ system failure by anti-toxin antibodies and prophylaxis by anaerobic toxoids

Compositions and methods for treating and preventing infections

TREATMENT OF RSV INFECTION

THERAPEUTIC AGENT FOR SOLID CANCER

Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant

COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY

Multispecific antibody platform and related methods

Proprotein convertase subtilisin kexin type 9 binding proteins and uses thereof

Compositions for inhibiting MASP-2 dependent complement activation

Anti-glyco-MUC1 antibodies and their uses

Anti-survivin antibodies for cancer therapy

Plectin-1 binding antibodies and uses thereof

Anti-SIRP-α antibodies and related methods

Pharmaceutical compositions comprising a polypeptide that binds to IL-6

ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF

Method of treating PVNS with anti-CSF1R antibodies

Anti-neuropilin antigen-binding proteins and methods of use thereof

HUMAN CTLA-4 ANTIBODIES AND THEIR USES

Humanized anti-rage antibody

Antibody drug conjugates

Anti-age antibodies for treating neurodegenerative disorders

Methods of treatment using activatable anti-EGFR antibodies

Method for treating breast cancer

HUMANIZED ANTIBODIES SPECIFIC TO THE PROTOFIBRILLAR FORM OF THE BETA-AMYLOID PEPTIDE

Enantiopure haptens for nicotine vaccine development

Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker

High-affinity anti-human folate receptor beta antibodies and methods of use

Humanized anti-CD40 antibodies and methods of administering thereof

ANTIGEN-BINDING MOLECULE FOR PROMOTING ELIMINATION OF ANTIGENS

T cell recruiting polypeptides based on TCR alpha/beta reactivity

Anti-CD3 antibodies and methods of use

COMPOSITIONS AND METHODS FOR THE DETECTION DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNANCIES

Humanized antibodies against CD269 (BCMA)

Trispecific proteins and methods of use

Antibodies to TIGIT

THERAPEUTIC CD47 ANTIBODIES

CDNA encoding a monoclonal anti-IL-32 antibody and methods for the production of the antibody

Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies

Anti-Tau antibodies and uses thereof

Anti-tau antibodies and uses thereof

Anti-Tau Antibodies and methods of use

Anti-Tau antibodies and methods of use

Separation of Triple-Light Chain Antibodies Using Cation Exchange Chromatography

HIGH-AFFINITY IMMUNOPOLYMERS

MODIFIED CHIMERIC RECEPTORS AND USES THEREOF IN IMMUNE THERAPY

Compositions and methods related to antibodies that neutralize coagulase activity during disease

Human antibodies to Tn antigen

ANTI-EGFR ANTIBODY DRUG CONJUGATE

IL-21 agonist antibodies and methods of treatment using same

MDR specific antibody

Methods of treating by administering anti-kit antibodies

Monoclonal antibodies against the active site of factor XI and uses thereof

CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

Anti-CD38 antibodies and methods of use

Antibody fab and Fc variants

Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases

Immunological reagents

Compositions and methods for treating cancer with anti-CD19 immunotherapy

Interferon alpha and omega antibody antagonists

Anti-IL-2 antibodies and compositions and uses thereof

Antibodies that specifically bind to TL1A and methods of treating respiratory tract diseases

Methods of treating fibromyalgia

CMV neutralizing antigen binding proteins

Engineered immune-mobilizing T-cell receptors with enhanced affinity for HIV-1 Gag

Antibody-drug conjugates and immunotoxins

Methods for selecting antibodies that specifically bind glycosylated immune checkpoint proteins

ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE

Anti-huLRRC15 antibody drug conjugates and methods for their use

Heterodimeric proteins and methods for producing and purifying them

Method of treating cancer by administering an anti-LGR5 monoclonal antibody

Methods of treating by administering anti-kit antibodies

Antibody polypeptides that antagonize CD40L

Multivalent and multispecific glucocorticoid-induced TNFR-related protein (GITR)-binding single-domain antibody fusion proteins and encoding nucleic acids

Anti-TIGIT antibodies

Antibody molecules to CD138 and uses thereof

IgG1 Fc MUTANTS WITH ABLATED EFFECTOR FUNCTIONS

Polypeptides that bind to IL-17A, IL-17F and/or IL17-A/F and methods of treatment using same

Optimized variants of anti-vegf antibodies and methods of use thereof in treatment

Anti-polyubiquitin antibodies and methods of use

Bispecific antigen-binding molecules that bind a target antigen and a complement component and uses thereof

Antibodies specific for enteroviruses that infect humans

ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE

ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE

T-CELL RECEPTOR MIMIC (TCRM) ANTIBODIES

Anti-TfR antibodies and their use in treating proliferative and inflammatory disorders

Anti-CXCR4 antibodies and antibody-drug conjugates

Binding proteins and methods of use thereof

Multispecific fab fusion proteins and use thereof

Antigen binding proteins that bind PD-L1

Covalent diabodies and uses thereof

Method of modulating the adrenomedullin (ADM) activity of a patient by administering to the patient an anti-ADM antibody or fragment thereof that specifically binds to mature human ADM

Method of treating osteoarthritis with human oncostatin M antibodies

Polypeptides

Interleukin-31 monoclonal antibody

Anti-interleukin-33 antibodies and uses thereof

Antibody molecules to a proliferation-inducing ligand (APRIL)

Anti-TNFα-antibodies and functional fragments thereof

TGFbeta 2 antibodies

Anti-ANGPTL3 antibodies and uses thereof

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same

Method for isolation of soluble polypeptides

T cell receptors

Anti-HER2 antibody-drug conjugate and application thereof

Anti-LAG3 antibodies and antigen-binding fragments

Methods and compositions for car T cell therapy

COMMON LIGHT CHAIN MOUSE

Phage-displayed single-chain variable fragment libraries and uses thereof

Specific plasmin inactivation by anticatalytic antibody

Anti-VWF D'D3 single-domain antibodies and methods of use

ANTI-C5 ANTIBODIES WITH ENHANCED PH SWITCH

ANTI-IL-6 RECEPTOR ANTIBODY

Methods of increasing progranulin levels using anti-Sortilin antibodies

B7-H4 antibodies and methods of use thereof

Siglec neutralizing antibodies

Anti-CD33 antibodies and methods of use thereof

LAG-3-binding molecules and methods of use thereof

Humanized anti-ACTH antibodies and use thereof

Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide

Antagonists to IL-6 to Raise Albumin and/or Lower CRP

Antagonists of IL-6 to prevent or treat cachexia, weakness, fatigue, and /or fever

IL-18 binding molecules

Compositions and methods for growth factor modulation

ANTIBODIES TO HGF AND COMPOSITIONS CONTAINING

COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION OF CANCERS

Methods for reducing migraine frequency in a subject in need thereof

Mast cell stabilizers for treatment of hypercytokinemia and viral infection

Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

ANTIBODIES TO IL-6 AND USE THEREOF

Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates

Anti-LAG3 antibodies and antigen-binding fragments

Anti-LAG3 antibodies and antigen-binding fragments

Anti-PD-1 antibodies and methods of use thereof

Coagulation factor-targeting to TREM-like transcript 1 (TLT-1) on activated platelets

Efficacy of anti-HLA-DR antibody drug conjugate IMMU-140 (hL243-CL2A-SN-38) in HLA-DR positive cancers

Synergistic effect of anti-trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitors

Mice expressing a limited immunoglobulin light chain repertoire

Engineered immunoglobulins with altered FcRn binding

Antibodies to ticagrelor and methods of use

NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE

Humanized anti-CD73 antibodies

Anti-human PD-L1 humanized monoclonal antibody and application thereof

Antibodies specific to glycosylated PD-1 and methods of use thereof

TIGIT-binding agents and uses thereof

Methods of treating ocular conditions by administering humanized monoclonal antibodies that target VE-PTP (HPTP-beta)

Humanized monoclonal antibodies that target protein tyrosine phosphatase-beta (HPTP-β/VE-PTP)

Anti-EphA4 antibody

ANTI-EMP2 THERAPY REDUCES CANCER STEM CELLS

Neutralizing antibodies to HIV-1 GP41 and their use

Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases

Compositions and methods for the depletion of CD137+ cells

FORMULATION FOR ANTI-ALPHA4BETA7 ANTIBODY